Ruke Unlimited's page

I'm making an Empiricist Investigator, 20 int skill monkey type character, and the two level dip into mind chemist is too good to pass up. But I do have a few questions.

1. If I take Infusion at level 2 from the Alchemist class, can I apply the infusion to my Investigator extracts? Likewise if I take, say, combine extracts as a Investigator, could I combine my Alchemist extracts?

2. Since it comes from two different class features, if I take the Mutagen discovery, and I imbibe a cognatogen (say, for int) and a mutagen (say, for dex) at the same time? Does this bypass the 1 mutagen in effect at a time clause?

And a question on a slightly different subject

Would the Inspired weapon ability be applicable to a Launching Crossbow? It seems like an oversight (the fact that the Launching X-Bow isn't a simple weapon actually seems like an oversight, but I digress). It seems like it applies to weapons that the Investigator might be proficient with, but hasn't been erratad to include that specific X-Bow. Followup question - would the conserving weapon trait return my Alchemist bombs, as well as any other ammo (tanglefoot bag, alchemist fire, etc...) to me should I, somehow, miss the targeted square?

I've been playing in an online game for a few months now. Starting off, the game was balanced and everything was going well. Just before the holidays however one of our players dropped and slowly but surely the party began to turn on my character (the party is LG, and though my character isn't evil, she was... morally ambiguous - the player that dropped was the same, so it balanced out and we had a very neutral-leaning good group of opportunists). After talking with the gm, we came to the conclusion that what would probably be best would be to semi-retire the character and move on. I enjoyed playing her, but c'est la vie. I created a generally likable halfling fighter who specialized in mounted combat. I was really just looking to play a character that could do well in a fight and otherwise sit on the sidelines and out of the spotlight (since my previous character was a bit of an attention hog).

Well, we just had our first session where I played this new character and, i guess for a lark, our gm thought it would be fun to have our level 5 barbarian fight a much higher level character from another game (judging from the battle, I would say that the other character was at least level 9 or 10). He required us to fight this character for critical information, and the barbarian had to wager his sword (+1 greatsword) against the other guys (+2 nodachi). The alternative was that our barbarian could get assistance, but wouldn't win the nodachi if he won. My new character offered assistance and against the odds (one round of attacks nearly killed our barbarian) we managed to beat him, thanks to a timely critical on my part.

Well, it seems like the gm isn't too happy about my new character. He messaged me later and said "That character is really annoying though. Mounted combat is the #1 thing I don't like". He's also basically said that he's going to be targeting me and my mount and/or designing encounters where I won't have the ability to utilize any of this characters potential.

So, I'm wondering if I should redesign my character (he just sent me a message saying that he would prefer if I would, but he won't make me), create a completely new character, stick it out with this new guy... I've played for a long time, but it's pretty rare that I make a character that the gm specifically wants to target (as in, I can't think of another time that it's happened, or at least where it was so apparent). I'm also questioning whether or not I fit in with this group and should continue to play with them. I enjoy playing with the, but I'm not sure they feel the same (it wasn't an established group before this game, its our first)

If I do redesign, are there any good suggestions? I normally play a magic user or a rogue and wanted to switch it up some, get out of my comfort zone with this fighter. Any thoughts or opinions are welcome.